The Burden of Disrupting Gastro-Oesophageal Reflux Disease: A Database Study in US and European Cohorts

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.30, Iss.3, 2010-03, pp. : 167-178

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Heartburn in Patients with Gastro-Oesophageal Reflux Disease in Germany and Sweden: A Study on Patients Burden of Disease

By Jones R.

PharmacoEconomics, Vol. 21, Iss. 15, 2003-01 ,pp. : 1091-1102

Adis International

Access to resources Recommend Favorite

Role of pantoprazole in the treatment of gastro-oesophageal reflux disease

By Lehmann Frank Serge Beglinger Christoph

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 1, 2005-01 ,pp. : 93-104

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for gastro-oesophageal reflux disease

By Wurm Peter De Caestecker John

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. : 457-471

Informa Healthcare

Access to resources Recommend Favorite

Review of rabeprazole in the treatment of gastro-oesophageal reflux disease

By Thjodleifsson Bjarni

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 1, 2004-01 ,pp. : 137-149

Informa Healthcare

Access to resources Recommend Favorite

Refractory Gastro-Oesophageal Reflux Disease: Diagnosis and Management

By Liu Julia J.

Drugs, Vol. 69, Iss. 14, 2009-10 ,pp. : 1935-1944

Adis International

Access to resources Recommend Favorite